Wei Li – Global Chief Investment Strategist, Alex Brazier – Deputy Head, Kurt Reiman – Senior Strategist for North America, and Carolina Martinez Arevalo – Portfolio Strategist all forming part of the BlackRock Investment Institute, share their insights on global economy, markets and geopolitics. Their views are theirs alone and are not intended to be construed as investment advice.
Key Points
Equity earnings: Stocks are starting to reflect the economic damage from higher rates – and we see more hikes due to sticky inflation. But expected earnings still look rosy to us.
Market backdrop: U.S. stocks fell over 4% last week and erased most of their gains for the year, partly after Fed officials made clear they could step up the pace of rate hikes.
Week ahead: This week’s U.S. inflation report will be a critical gauge before the Fed’s next policy meeting. The European Central Bank is likely to raise rates by 0.5%.
Stocks are starting to reflect the economic damage of rate hikes. We think earnings offer little support – expectations for this year are still too rosy. We think corporate margins could get hit by higher costs and reduced pricing power as goods shortages ease. We see an earnings hit on top of that from recession as central banks fight sticky inflation – and are poised to hold rates higher for longer. We prefer short-term bonds for income and emerging market (EM) equities.
Profit margins at risk
We are not in a typical economic cycle. Tight labor markets are driving persistently higher inflation. That’s why we see major central banks creating economic damage and recession as they try to bring inflation down to their 2% targets. We think this is a tough backdrop for earnings – and could get worse as profit margins are squeezed. Companies’ pricing power had increased as the pandemic-driven demand for goods created shortages. But now spending patterns are normalizing back to services and away from goods, so that pricing power is waning. This comes just as cost pressures are mounting from higher wages and funding costs. We expect a recession to hit sales and higher costs to pinch margins still near historically high levels. See the chart. That should crunch corporate earnings and is why we think the consensus for flat earnings in the S&P 500 for 2023 as a whole is still too optimistic.
Good economic news – as seen in the February U.S. payroll gains, confirming a tight labor market – only adds to the risk that central banks will push policy rates even higher and keep them there, we think. This is an important lens through which we see the new regime of greater macro and market volatility playing out – and why good growth news could actually be bad news for markets.
Sector lens
We prefer short-term government bonds offering attractive income over developed market (DM) equities given the risks we see to earnings. Equities are starting to better price in the economic damage we see ahead. Yet we think being selective is key. We prefer the energy sector as tight supply buoys energy prices. We also like healthcare for its defensive characteristics in a downturn and financials due to higher rates and profit margins – even with potential risks. The U.S. stock market’s concentration of tech and consumer discretionary companies make it more exposed to the wage pressures from a tight labor market, in our view. Earnings results from the fourth quarter of 2022 showed revenue growth slowing, and earnings contracted for the first time since late 2020. Both managed to top already lowered consensus expectations – but the earnings beat was the smallest in a decade, we find. We think this shows how inflation can hit earnings – especially with pressure from higher costs related to wages.
European companies face similar constraints in the labor market. Yet we see some support for European stocks because of a large concentration of financial and energy companies we like. We also think the consumer discretionary sector in Europe is set up to benefit from higher demand for luxury goods from China’s economic restart.
Emerging over developed markets
China’s restart is also an important reason why we prefer EM stocks over DM. We think it helps brighten the overall economic backdrop in EM compared with DM economies. We also think risks are better priced: EM central bank rate hiking cycles are closer to their peak, and the U.S. dollar is still broadly weaker from its 2022 peak – even with its strength this year.
Our bottom line
We think markets are waking up to the risks from the fastest rate hiking cycle since the 1980s. For now, we like short-term government bonds for income. We’re overweight EM stocks and prefer them to DM peers: We think risks are better priced in EM. We’re modestly underweight DM stocks. We think earnings expectations are still too high, so we look for granular opportunities in sectors instead.
Market backdrop
U.S. stocks fell more than 4% last week and erased most gains for the year after Fed Chair Jerome Powell suggested it could pick up the pace of rate hikes and financial cracks emerged. We think the market is also starting to reflect the economic damage stemming from the rapid rate hikes of the past year. U.S. two-year yields fell sharply after hitting 16-year highs to price out rate hikes. We think rates are headed higher and the inflation problem for central banks remains the same.
The U.S. CPI inflation data for February will be a critical gauge ahead of the Fed’s policy decision later this month. Markets are waking up to the risk that rates could stay higher for longer as labor market tightness persists and core inflation proves sticky. In Europe, the ECB is likely to raise rates by 0.5% to 2.5%, and we’re watching for updated economic projections.
Week Ahead
Mar 14: U.S. CPI inflation
Mar 16: ECB policy decision
Mar 17: University of Michigan consumer sentiment survey
BlackRock’s Key risks & Disclaimers:
This material is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of 13th March, 2023 and may change. The information and opinions are derived from proprietary and non-proprietary sources deemed by BlackRock to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. As such, no warranty of accuracy or reliability is given and no responsibility arising in any other way for errors and omissions (including responsibility to any person by reason of negligence) is accepted by BlackRock, its officers, employees or agents. This material may contain ’forward looking’ information that is not purely historical in nature. Such information may include, among other things, projections and forecasts. There is no guarantee that any forecasts made will come to pass. Reliance upon information in this material is at the sole discretion of the reader.
The information provided here is neither tax nor legal advice. Investors should speak to their tax professional for specific information regarding their tax situation. Investment involves risk including possible loss of principal. International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation, and the possibility of substantial volatility due to adverse political, economic or other developments. These risks are often heightened for investments in emerging/developing markets or smaller capital markets.
Issued by BlackRock Investment Management (UK) Limited, authorized and regulated by the Financial Conduct Authority. Registered office: 12 Throgmorton Avenue, London, EC2N 2DL.
MeDirect Disclaimers:
This information has been accurately reproduced, as received from BlackRock Investment Management (UK) Limited. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.
The financial instruments discussed in the document may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.
If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Information Document (KID), which may be obtained from MeDirect Bank (Malta) plc.
